Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Jim Gaffigan Talks Weight Loss With Mounjaro
Actor-Comedian Jim Gaffigan Opens Up About Weight Loss Journey with Mounjaro And Struggles With Food Addiction
Jim Gaffigan reveals his weight loss journey with Mounjaro tackling food addiction and societal stigma while balancing comedy parenting and new ventures
Jim Gaffigan Makes a Bold Declaration About Using Weight Loss Drugs Like Mounjaro
Fans who watched Jim Gaffigan play Tim Walz on Saturday Night Live throughout election season might have noticed something different about the comedian—his noticeably slimmer frame. In a recent interview with Us Weekly,
Jim Gaffigan Talks Weight Loss With Mounjaro: ‘There’s Less Sympathy’ for Food Addiction (Exclusive)
Jim Gaffigan exclusively told Us Weekly about using the weight loss drug Mounjaro and why food addiction gets "less sympathy"
Jim Gaffigan Reflects on Weight Loss Journey, How He Finally Slimmed Down
Jim Gaffigan has always used his weight and love for eating as a punchline in his comedy, even going so far to title his 2013 memoir Dad Is Fat. But the 58-year-old recently lost a significant amount of weight with the anti-diabetic medication Mounjaro, and is now opening up about his weight loss journey.
What UK’s first Mounjaro-linked death means for future of weight-loss jabs
Susan McGowan took two doses of tirzepatide, sold under the brand name Mounjaro, before she died on 4 September
2h
99% Of Mounjaro/Zepbound Patients Remained Diabetes-Free Even At 3 Years, Eli Lilly's Detailed Phase 3 Data Shows
Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.
tyla
2d
Company behind weight loss drug Mounjaro issues statement as first Brit dies after using jab twice
Company behind weight loss drug Mounjaro, Lilly, has issued an official statement after British woman, Susan McGowan, died ...
Becker's Hospital Review
3h
Mounjaro lowers Type 2 diabetes risk in phase 3 trial: Study
A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated ...
FiercePharma
23h
Lilly unwraps detailed data showing tirzepatide kept nearly 99% of prediabetic patients diabetes-free over 3 years
Following an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression ...
tyla
7d
Mounjaro explained as Adam Lambert speaks out on drastic weight loss and why he stopped taking Ozempic
Mounjaro explained as Adam Lambert speaks out on Instagram live about his drastic weight loss and why he stopped taking ...
8h
2 Top Growth Stocks to Buy on the Dip
Has something changed regarding Eli Lilly or Regeneron's thesis, or is the recent dip an excellent opportunity to invest in ...
4d
Influencers hold Mounjaro weight loss jab party - miles from where 'nurse' died taking it
An influencer, known as Heather, has organised a party celebrating weight loss jab tirzepatide, close to where NHS worker ...
The New York Times
22h
Ozempic Could Prevent Diabetes. Should It Be Used for That?
The new paper, published Wednesday in The New England Journal of Medicine, showed that the compound in the diabetes drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Weight loss
Susan McGowan
Jim Gaffigan
Ozempic
National Health Service
Feedback